Local recurrence of pancreatic cancer after primary surgical intervention: How to deal with this devastating scenario?

Surgical Oncology

Volumn 20, Issue 4, 2011, Pages

  Kyriazanos, Ioannis D ^a   Tsoukalos, Grigorios G ^a   Papageorgiou, Georgios ^a   Verigos, Kosmas E ^b   Miliadis, Lazaros ^a   Stoidis, Christos N ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b Department of Radiation Oncology   (Greece)

Author keywords

Cyberknife; Local recurrence; Pancreaticoduodenectomy; Portal hypertension; Portal vein stenting

Indexed keywords

CISPLATIN; ENOXAPARIN; FLUOROURACIL; GEMCITABINE;

ABDOMINAL DISCOMFORT; AGED; ANEMIA; ANTICOAGULANT THERAPY; BALLOON DILATATION; BLOATING; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL EFFECTIVENESS; COLONOSCOPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYBERKNIFE; DECOMPRESSION; DIARRHEA; ENDOSCOPIC ECHOGRAPHY; ENDOVASCULAR SURGERY; ESOPHAGUS VARICES; FATIGUE; FOLLOW UP; HEMATEMESIS; HUMAN; INTESTINE DISTENSION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MESENTERY VARICES; MONOTHERAPY; NAUSEA; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATICODUODENECTOMY; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; REVASCULARIZATION; REVIEW; SPLENIC VEIN; STENT; STEREOTACTIC BODY RADIATION THERAPY; STOMACH VARICES; SUPERIOR MESENTERIC ARTERY; TREATMENT PLANNING; VARICOSIS; VEIN OCCLUSION;

AGED; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053629197     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2011.04.004     Document Type: Review

References (55)

1. O. Mann, T. Strate, C. Schneider, E.F. Yekebas, and J.R. Izbicki Surgery for advanced and metastatic pancreatic cancer-current state and perspectives Anticancer Res 26 2006 681 686 (Pubitemid 43206034)
2. G. Barugola, S. Partelli, S. Marcucci, N. Sartori, P. Capelli, and C. Bassi Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol 16 2009 3316 3322
3. H. Riediger, T. Keck, U. Wellner, A. zur Hausen, U. Adam, and U.T. Hopt The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer J Gastrointest Surg 13 2009 1337 1344
4. T.J. Kinsella, Y. Seo, J. Willis, T.A. Stellato, C.T. Siegel, and D. Harpp The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer Am J Clin Oncol 31 2008 446 453
5. A. Van den Broeck, G. Sergeant, N. Ectors, W. Van Steenbergen, R. Aerts, and B. Topal Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma Eur J Surg Oncol 35 2009 600 604
6. J.M. Hernandez, C.A. Morton, S. Al-Saadi, D. Villadolid, J. Cooper, and C. Bowers The natural history of resected pancreatic cancer without adjuvant chemotherapy Am Surg 76 2010 480 485
7. B. Asiyanbola, A. Gleisner, J.M. Herman, M.A. Choti, C.L. Wolfgang, and M. Swartz Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio J Gastrointest Surg 13 2009 752 759
8. C. Sharma, K.M. Eltawil, P.D. Renfrew, M.J. Walsh, and M. Molinari Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010 World J Gastroenterol 17 2011 867 897
9. R. Wilkowski, M. Thoma, C. Bruns, E. Dühmke, and V. Heinemann Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer JOP 7 2006 34 40 (Pubitemid 43103797)
10. S.E. Greer, J.M. Pipas, J.E. Sutton, B.I. Zaki, M. Tsapakos, and T.A. Colacchio Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma J Am Coll Surg 206 2008 451 457
11. J. Kleeff, C. Reiser, U. Hinz, J. Bachmann, J. Debus, and D. Jaeger Surgery for recurrent pancreatic ductal adenocarcinoma Ann Surg 245 2007 566 572 (Pubitemid 46555660)
12. T. Zacharias, E. Oussoultzoglou, D. Jaeck, P. Pessaux, and P. Bachellier Surgery for recurrence of periampullary malignancies J Gastrointest Surg 13 2009 760 767
13. G. Barugola, M. Falconi, R. Bettini, L. Boninsegna, A. Casarotto, and R. Salvia The determinant factors of recurrence following resection for ductal pancreatic cancer JOP 8 2007 132 140
14. L. Capussotti, P. Massucco, D. Ribero, L. Vigan, A. Muratore, and M. Calgaro Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy Arch Surg 138 2003 1316 1322 (Pubitemid 37499388)
15. S. Miyakawa, S. Ishihara, T. Takada, M. Miyazaki, K. Tsukada, and M. Nagino Flowcharts for the management of biliary tract and ampullary carcinomas J Hepatobiliary Pancreat Surg 15 2008 7 14 (Pubitemid 351279836)
16. T.N. Showalter, A.S. Rao, P. Rani Anne, F.E. Rosato, E.L. Rosato, and J. Andrel Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis Ann Surg Oncol 16 2009 2116 2122
17. J. Richter, and M.W. Saif Updates in adjuvant therapy in pancreatic cancer: gemcitabine and beyond. Highlights from the "2010 ASCO gastrointestinal cancers symposium". Orlando, FL, USA. January 22-24, 2010 JOP 11 2010 144 147
18. D.W. Maximous, M.E. Abdel-Wanis, M.I. El-Sayed, and A.A. Abd-Elsayed Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Int Arch Med 2 2009 7
19. R. Wilkowski, M. Thoma, C. Bruns, A. Wagner, and V. Heinemann Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer JOP 7 2006 349 360 (Pubitemid 44083106)
20. K. Ogawa, H. Shibuya, N. Uchida, H. Onishi, Y. Okuno, M. Myojin JROSG Working Subgroup of Gastrointestinal Cancer Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: impact of chemotherapy on local control and survival Anticancer Res 30 2010 2959 2967
21. H. Ashamalla, B. Zaki, B. Mokhtar, F. Colella, H. Selim, and M. Krishnamurthy Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 55 2003 679 687 Erratum in: Int J Radiat Oncol Biol Phys. 2003; 55: 1158 (Pubitemid 36170009)
22. N. Spry, J. Harvey, G. Macleod, M. Borg, S.Y. Ngan, and J.L. Millar 3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome Int J Radiat Oncol Biol Phys 70 2008 1438 1446
23. C.C. Hsu, J.M. Herman, M.M. Corsini, J.M. Winter, M.D. Callister, and M.G. Haddock Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study Ann Surg Oncol 17 2010 981 990
24. H. Ohigashi, O. Ishikawa, H. Eguchi, H. Takahashi, K. Gotoh, and T. Yamada Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer Ann Surg 250 2009 88 95
25. H. Horiuchi, S. Uchida, T. Hisaka, H. Ishikawa, T. Sakai, and R. Kawahara A study of recurrent pancreatic cancer with metastatic liver tumors after pancreatectomy Gan To Kagaku Ryoho 32 2005 1685 1687
26. M.L.C. Wang, and K.F. Foo Adjuvant chemoradiotherapy for highrisk pancreatic cancer Singapore Med J 50 2009 43
27. R. Le Scodan, F. Mornex, N. Girard, C. Mercier, P.J. Valette, and M. Ychou Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review Ann Oncol 20 2009 1387 1396
28. S. Satoi, H. Yanagimoto, H. Toyokawa, K. Takahashi, Y. Matsui, and H. Kitade Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer Pancreas 38 2009 282 288
29. O. Turrini, F. Viret, L. Moureau-Zabotto, J. Guiramand, V. Moutardier, and B. Lelong Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma Eur J Surg Oncol 35 2009 1306 1311
30. S. Krishnan, V. Rana, N.A. Janjan, J.L. Abbruzzese, M.S. Gould, and P. Das Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation Cancer 107 2006 2589 2596 (Pubitemid 44845612)
31. A.G. Morganti, F. Forni, G. Macchia, V. Valentini, D. Smaniotto, and L. Trodella Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure Strahlenther Onkol 179 2003 87 92 (Pubitemid 36216174)
32. Y.J. Kim, D.W. Seo, K.M. Pack, E. Jeong, S.C. Kim, and D.J. Han The prognostic factors of pancreatic cancer can be different according to clinical stages Korean J Gastroenterol 51 2008 181 189
33. X.B. Zhang, J.H. Wang, Z.P. Yan, S. Qian, S.S. Du, and Z.C. Zeng Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization Cancer 115 2009 1245 1252
34. J.-P. Heyne, S.O.R. Pfleiderer, G. Trebing, J. Scheele, and W.A. Kaiser Palliative portal vein stent placement for lymphatic recurrence of gastric cancer Int J Colorectal Dis 20 2005 67 71 (Pubitemid 40057880)
35. K.B. Park, S.W. Choo, Y.S. Do, S.W. Shin, S.G. Cho, and I.-W. Choo Percutaneous angioplasty of portal vein stenosis that complicates liver transplantation: the mid-term therapeutic results Korean J Radiol 6 2005 161 166 (Pubitemid 41296875)
36. H.L. Chen, A.M. Concejero, T.L. Huang, T.Y. Chen, L.L.C. Tsang, and C.C. Wang Diagnosis and interventional radiological treatment of vascular and biliary complications after liver transplantation in children with biliary atresia Transplant Proc 40 2008 2534 2536
37. X.B. Zhang, J.H. Wang, Z.P. Yan, S. Qian, and R. Liu Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting Cardiovasc Intervent Radiol 32 2009 52 61
38. K. Hiraoka, S. Kondo, Y. Ambo, S. Hirano, M. Omi, and S. Okushiba Portal venous dilatation and stenting for bleeding jejunal varices: report of two cases Surg Today 31 2001 1008 1011 (Pubitemid 33141289)
39. M. Sakai, A. Nakao, T. Kaneko, S. Takeda, S. Inoue, and Y. Yagi Transhepatic portal venous angioplasty with stenting for bleeding jejunal varices Hepatogastroenterology 52 2005 749 752 (Pubitemid 40834597)
40. R. Uflacker Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis Techniq Vasc Intervent Radiol 6 2003 59 69 (Pubitemid 36605509)
41. S. Hwang, K.B. Sung, Y.H. Park, D.H. Jung, and S.G. Lee Portal vein stenting for portal hypertension caused by local recurrence after pancreatoduodenectomy for periampullary cancer J Gastrointest Surg 11 2007 333 337
42. C.M. Ellis, S. Shenoy, A. Litwin, S. Soehnlein, and J.F. Gibbs Effective endovascular stenting of malignant portal vein obstruction in pancreatic cancer HPB Surg 2009 2009 426436
43. H. Ueno, and T. Kosuge Adjuvant treatments for resectable pancreatic cancer J Hepatobiliary Pancreat Surg 15 2008 468 472
44. M. Sarfaraz CyberKnife robotic arm stereotactic radiosurgery J Am Coll Radiol 4 2007 563 565 (Pubitemid 47095469)
45. C. Sperti, C. Pasquali, S. Bissoli, F. Chierichetti, G. Liessi, and S. Pedrazzoli Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT J Gastrointest Surg 14 2010 131 140
46. J. Ruf, E. Lopez Hanninen, H. Oettle, M. Plotkin, U. Pelzer, and C. Stroszczynski Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI Pancreatology 5 2005 266 272 (Pubitemid 40754748)
47. Y. Seo, M.S. Kim, S. Yoo, C. Cho, K. Yang, and H. Yoo Stereotactic body radiation therapy boost in locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 75 2009 1456 1461
48. J.C. Rwigema, D.E. Heron, S.D. Parikh, H.J. Zeh 3rd, J.A. Moser, and N. Bahary Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins J Gastrointest Cancer 2010
49. J.S. Cupp, A.C. Koong, G.A. Fisher, J.A. Norton, and K.A. Goodman Tissue effects after stereotactic body radiotherapy using cyberknife for patients with abdominal malignancies Clin Oncol (R Coll Radiol) 20 2008 69 75
50. D.T. Chang, D. Schellenberg, J. Shen, J. Kim, K.A. Goodman, and G.A. Fisher Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
51. M.K. Sanders, A.J. Moser, A. Khalid, K.E. Fasanella, H.J. Zeh, and S. Burton EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer Gastrointest Endosc 71 2010 1178 1184
52. J.C. Rwigema, S.D. Parikh, D.E. Heron, M. Howell, H. Zeh, and A.J. Moser Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas Am J Clin Oncol 2010
53. M.S. Didolkar, C.W. Coleman, M.J. Brenner, K.U. Chu, N. Olexa, and E. Stanwyck Image-guided stereotactic radiosurgery for locally advanced pancreatic adenocarcinoma results of first 85 p.tients J Gastrointest Surg 14 2010 1547 1559
54. M. Wagner, C. Redaelli, M. Lietz, C.A. Seiler, H. Friess, and M.W. Büchler Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 2004 586 594 (Pubitemid 38624667)
55. C. Sperti, C. Pasquali, A. Piccoli, and S. Pedrazzoli Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 1997 195 200 (Pubitemid 27053441)